Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,207 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07343349Recruiting
Adding a higher radiation dose to prostate tumors during standard radiotherapy
This trial tests whether giving an extra, focused dose of radiation to the visible tumor inside the prostate can improve results for men with intermediate or high-risk prostate cancer that has not spread. The total treatment is given in 12 or 20 sessions.
AarhusAges 18 years+ - NCT07340463RecruitingPhase 2
Biologics vs standard therapy for lupus kidney disease
This trial tests two biologic drugs (belimumab or telitacicept) compared to a standard treatment (mycophenolate mofetil) for people with active lupus nephritis. The goal is to see if biologics work better at controlling kidney inflammation over 6 months.
Nanjing, JiangsuAges 14–65 - NCT07334379RecruitingPhase 2
Personalized treatment for hospitalized patients with breathing problems
This study tests a personalized approach for hospitalized patients with acute breathing problems. It uses a blood test to guide whether they receive a common steroid or a targeted medication (tocilizumab) to reduce inflammation, with the goal of improving recovery.
Toronto, OntarioAges 18 years+ - NCT07338682RecruitingPhase 2
L-Arginine for memory in older adults
This trial tests if L-Arginine, a natural amino acid, can improve thinking and memory in adults over 60 with mild to moderate memory problems. You may join if you have no other brain diseases or certain health conditions.
CairoAges 60 years+ - NCT07341360RecruitingEarly Phase 1
Cancer vaccine trial for pseudomyxoma peritonei
This trial tests a vaccine for people with a rare abdominal cancer called pseudomyxoma peritonei (PMP) that has come back or cannot be removed by surgery. The vaccine is designed to help the immune system fight the cancer. It is for people whose tumor has a specific genetic change (GNAS mutation) and who have no other standard treatment options.
Oslo, OsloAges 18 years+ - NCT07335887RecruitingPhase 2
Sonrotoclax and dexamethasone with or without daratumumab for AL amyloidosis with t(11;14)
This trial tests a new drug combination for people with a specific type of AL amyloidosis (light chain amyloidosis) that has a genetic marker called t(11;14). The treatment includes Sonrotoclax (a targeted therapy) plus steroids, and possibly another drug called daratumumab, to see if it can help control the disease.
BeijingAges 18 years+ - NCT07335679Recruiting
Strasbourg adrenal cancer patient study
This study looks at patients with adrenal cortex carcinoma who were treated at Strasbourg University Hospital. It aims to better understand the condition and its outcomes.
StrasbourgAges 18 years+ - NCT07342647Recruiting
Safer antibiotics for people with beta-lactam allergies in joint replacement surgery
This trial tests a better way to choose antibiotics during joint replacement surgery for patients who are allergic to beta-lactams (a common class of antibiotics). The goal is to prevent infections while avoiding allergic reactions.
StrasbourgAges 18 years+ - NCT07339449Recruiting
Monitoring during surgery to reduce time on a breathing tube
This study tests whether special monitors used during major abdominal surgery can help high-risk patients wake up sooner and need a breathing tube for less time after the operation.
Zagreb, CroatiaAges 50 years+ - NCT07342920Recruiting
Smoking and vaping in adults with cystic fibrosis
This study looks at how many adults with cystic fibrosis smoke or vape (use e-cigarettes). It aims to understand how common these habits are in this group.
StrasbourgAges 18 years+ - NCT07335302Recruiting
Study to improve comfort during brachytherapy device removal
This study looks at improving comfort and reducing distress when removing the internal device used in brachytherapy (a type of radiation) for gynecologic cancer. You will be asked to fill out surveys about how you feel before, during, and after the removal.
Houston, TexasAges 18 years+ - NCT07343024Recruiting
Finding a Personalized Drug for Advanced Cancer
This trial looks at whether drugs not usually used for your type of cancer can help you. It matches your tumor's test results to possible treatments and works with your doctor to try one.
Palo Alto, CaliforniaAges Any age - NCT07337564RecruitingPhase 2
Study of SHR-1139 for ulcerative pyoderma gangrenosum
This study tests an investigational drug called SHR-1139 for adult patients with ulcerative pyoderma gangrenosum (a type of painful skin ulcer). The goal is to see if the drug is safe and helps heal the ulcers.
Jinan, ShandongAges 18 years+ - NCT07342205RecruitingPhase 2/Phase 3
Fecal transplant for sepsis-related lung injury
This study tests if transferring healthy gut bacteria (fecal microbiota transplant) can help people with acute lung injury caused by sepsis. It aims to reduce inflammation and improve breathing.
Shanghai, PutuoAges 18 years+ - NCT07335705Recruiting
Factors affecting bowel prep in IBD patients
This study looks at factors that affect how well the bowel is cleaned before a colonoscopy in people with IBD. The goal is to improve preparation so the colonoscopy can be more effective.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07343089Recruiting
Study of Lyme disease during anti-CD20 treatment in France
This study looks at people who got a serious form of Lyme disease while being treated with a type of biologic drug called an anti-CD20 (such as rituximab). The goal is to learn more about these cases and improve care. You may join if you had Lyme disease confirmed by a DNA test within two years of taking this medicine.
StrasbourgAges 1 year+ - NCT07342036Recruiting
Study of new heart device leads and tricuspid valve leakage
This study looks at how a new pacemaker or defibrillator lead may affect the tricuspid valve (the valve between the right upper and lower heart chambers). It helps doctors understand if the lead causes leakage (regurgitation) over time.
Bad Oeynhausen, North Rhine-WestphaliaAges 18 years+ - NCT07334392Recruiting
Exercise program for mild memory problems
This trial tests if a supervised exercise program can improve thinking skills and daily function in people with mild cognitive impairment (MCI). It may help slow memory decline and keep you independent longer.
PátraiAges 50 years+ - NCT07340125Recruiting
Pistachio snacking and metabolic flexibility study
This study tests whether eating pistachios as a snack can improve how your body uses energy and manages metabolism. It looks at people who are overweight, sleep poorly, and don't exercise much.
Columbia, South CarolinaAges 25–45 - NCT07335900Recruiting
Studying heart healing after TAVI with FAPI-PET scan
This study uses a special type of PET scan (FAPI-PET) to see how the heart heals after a less invasive valve replacement procedure called TAVI. It aims to help doctors better understand the changes in heart tissue after treatment for aortic stenosis.
ShanghaiAges 18 years+ - NCT07336225Recruiting
CMR Study for Heart Device Patients
This study looks at people who already had a heart MRI before getting a pacemaker, defibrillator, or other heart device. It aims to learn how MRI results might predict long-term outcomes for these patients.
BeijingAges 18 years+ - NCT07339254Recruiting
Survey about immunotherapy for lung cancer patients
This study is a survey to learn about the experiences and feelings of people with non-small cell lung cancer who are taking immunotherapy drugs. The goal is to understand how you're doing on treatment, which can help improve care for others.
Los Angeles, CaliforniaAges 18 years+ - NCT07334210Recruiting
Gut bacteria in sarcopenia and probiotic development
This study looks at gut bacteria differences between older adults with muscle loss (sarcopenia), healthy older adults, and younger adults. Results may help develop probiotics to support muscle health.
Seongnam-si, Gyeonggi-doAges 20–90 - NCT07341282RecruitingPhase 2
Vancomycin for ulcerative colitis with liver condition
This trial tests whether the antibiotic vancomycin can help treat active ulcerative colitis in people who also have primary sclerosing cholangitis (a liver condition). Vancomycin may reduce inflammation in the gut by changing the bacteria in your intestines.
Hamilton, OntarioAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,207 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.